Evidence map›Paper›PMID 39974056›Full record

ArticlemedRxiv : the preprint server for health sciences2025

OPPORTUNISTIC ASSESSMENT OF CARDIOVASCULAR RISK USING AI-DERIVED STRUCTURAL AORTIC AND CARDIAC PHENOTYPES FROM NON-CONTRAST CHEST COMPUTED TOMOGRAPHY.

Daniel W Oo, Audra Sturniolo, Matthias Jung, Marcel Langenbach, Borek Foldyna, Douglas P Kiel, Hugo Jwl Aerts, Pradeep Natarajan, Michael T Lu, Vineet K Raghu

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniel W OoCardiovascular Imaging Research Center (CIRC), Department of Radiology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States of America.ORCID 0009-0003-9847-9952
Audra SturnioloCardiovascular Imaging Research Center (CIRC), Department of Radiology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States of America.
Matthias JungCardiovascular Imaging Research Center (CIRC), Department of Radiology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States of America.
Marcel LangenbachCardiovascular Imaging Research Center (CIRC), Department of Radiology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States of America.
Borek FoldynaCardiovascular Imaging Research Center (CIRC), Department of Radiology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States of America.
Douglas P KielHinda and Arthur Marcus Institute on Aging Research, Hebrew SeniorLife, Department of Medicine, Beth Israel Deaconess Medical Center & Harvard Medical School, Boston, MA, United States of America.
Hugo Jwl AertsCardiovascular Imaging Research Center (CIRC), Department of Radiology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States of America.
Pradeep NatarajanCardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States of America.
Michael T LuCardiovascular Imaging Research Center (CIRC), Department of Radiology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States of America.
Vineet K RaghuCardiovascular Imaging Research Center (CIRC), Department of Radiology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States of America.

Funding

Deep learning to assess cardiovascular disease risk from chest imagingK01HL168231 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Vineet Raghu · 2024 to 2026
$526k
NHLBI NIH HHS K01 HL168231
6 · The paper itself

Abstract

Background: Primary prevention of cardiovascular disease relies on accurate risk assessment using scores such as the Pooled Cohort Equations (PCE) and PREVENT. However, necessary input variables for these scores are often unavailable in the electronic health record (EHR), and information from routinely collected data (e.g., non-contrast chest CT) may further improve performance. Here, we test whether a risk prediction model based on structural features of the heart and aorta from chest CT has added value to existing clinical algorithms for predicting major adverse cardiovascular events (MACE). Methods: We developed a LASSO model to predict fatal MACE over 12 years of follow-up using structural radiomics features describing cardiac chamber and aorta segmentations from 13,437 lung cancer screening chest CTs from the National Lung Screening Trial. We compared this radiomics model to the PCE and PREVENT scores in an external testing set of 4,303 individuals who had a chest CT at a Mass General Brigham site and had no history of diabetes, prior MACE, or statin treatment. Discrimination for incident MACE was assessed using the concordance index. We used a binary threshold to determine MACE rates in patients who were statin-eligible or ineligible by the PCE/PREVENT scores (≥7.5% risk) or the radiomics score (≥5.0% risk). Results were stratified by whether all variables were available to calculate the PCE or PREVENT scores. Results: In the external testing set (n = 4,303; mean age 61.5 ± 9.3 years; 47.1% male), 8.0% had incident MACE over a median 5.1 years of follow-up. The radiomics risk score significantly improved discrimination beyond the PCE (c-index 0.653 vs. 0.567, p < 0.001) and performed similarly in individuals who were missing inputs. Those statin-eligible by both the radiomics and PCE scores had a 2.6-fold higher incidence of MACE than those eligible by the PCE score alone (29.5 [20.5, 39.1] vs. 11.2 [8.0, 14.4] events per 1,000 person-years among PCE-eligible individuals). In patients missing inputs, incident MACE rates were 1.8-fold higher in those statin-eligible by the radiomics score than those statin-ineligible (29.5 [21.9, 37.6] vs. 16.7 [14.3, 19.0] events per 1000 person-years). Similar results were found when comparing to the PREVENT score. Left ventricular volume and short axis length were most predictive of myocardial infarction, while left atrial sphericity and surface-to-volume ratio were most predictive of stroke. Conclusions: Based on a single chest CT, a cardiac shape-based risk prediction model predicted cardiovascular events beyond clinical algorithms and demonstrated similar performance in patients who were missing inputs to standard cardiovascular risk calculators. Patients at high-risk by the radiomics score may benefit from intensified primary prevention (e.g., statin prescription).

Identifiers

PMID39974056
PMCPMC11839003

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.